Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

Drugmakers are pushing back against pharmaceutical tariffs. Some companies are lobbying the Trump administration to phase in ...

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...

Jim Tananbaum, MD and the Founder and CEO of Foresite Capital, a US-focused health-care investment firm says the sector is ...

Exclusive reporting on Munster, national and international business news and how it impacts Ireland and the poeple who live ...

Many investor eyes were on the pharmaceutical industry on Tuesday, and not necessarily for the right reasons. The Trump ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has earned a consensus rating of “Moderate Buy” from the ...

Citi believes that Pharma companies will aim to pass on the tariff hikes to payors. In case the costs are not passed on to ...

No matter how high the inflation is, their demand is inelastic. No matter how slow the current profit growth is, these ...

Drugmakers have argued that tariffs could increase the chance of drug shortages and reduce access for patients.

The pharmaceutical industry isn’t happy about President Donald Trump’s trade war and is reportedly lobbying the President to slow down drug ...

Drugmakers are lobbying President Trump to phase in tariffs on imported pharmaceutical products to alleviate the impact and ...